(CIDRAP News) The Food and Drug Administration (FDA) this week endorsed a widespread cosmetic procedure by approving the use of botulinum toxin type A to temporarily smooth frown lines between the eyebrows.
(CIDRAP News) The United States' food supply makes an attractive target for terrorists, and people in the food industry need to talk more frankly about the risks, bioterrorism expert Michael T. Osterholm, PhD, MPH, said in a Minneapolis speech yesterday.
Editor's note: This story was updated Jan 30, 2003, with additional information from the Department of Health and Human Services.
(CIDRAP News) – President Bush yesterday proposed an initiative, called Project Bioshield, to speed the development and production of vaccines and treatments for smallpox, anthrax, botulism, and other diseases that could be spread by terrorists.
(CIDRAP News) Six months after President Bush proposed the idea, the US House this week overwhelmingly passed "Project Bioshield," a plan to promote the development of drugs and vaccines needed to defend the nation against attacks with biological and other unconventional weapons.
(CIDRAP News) Florida officials said today that botulism has been confirmed in three of four suspected cases linked with a Florida clinic that reportedly gave injections with anti-wrinkle preparations containing botulinum toxin, but whether the cases stemmed from such injections remained unknown.
(CIDRAP News) – Four Floridians suffering from botulism were injected with massive doses of a botulinum toxin that was not approved for use on humans, according to news reports based on court documents filed by the Food and Drug Administration (FDA)
(CIDRAP News) Several healthcare professionals have been suspended and an Arizona company has been shut down in the investigation launched last November when four Floridians were paralyzed by injections with a botulinum toxin not approved for use in humans.
(CIDRAP News) A human-derived antitoxin for babies with botulism shortened their hospital stays by an average of more than 3 weeks and reduced average hospital bills by about $88,000 in a randomized trial, according to a recent report.